• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR Back to Search Results
Catalog Number UNK CDS
Device Problems Positioning Failure (1158); Incomplete Coaptation (2507)
Patient Problems Stroke/CVA (1770); Fistula (1862); Hemorrhage/Bleeding (1888); Unspecified Infection (1930); Myocardial Infarction (1969); Perforation (2001); Pneumonia (2011); Renal Failure (2041); Cardiogenic Shock (2262); Pseudoaneurysm (2605); Heart Failure/Congestive Heart Failure (4446); Mitral Valve Insufficiency/ Regurgitation (4451)
Event Date 01/31/2012
Event Type  malfunction  
Manufacturer Narrative
Date of event - estimated the unique device identifier (udi) is unknown because the part and lot numbers were not provided.Implant date is - estimated the clip remains in patient.The device will not be returned for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Article attached: acute and midterm outcome after mitraclip therapy in patients with severe mitral regurgitation and left ventricular dysfunction the patient events mentioned in the article and are filed under different medwatch mfr numbers.
 
Event Description
This is filed to report the single leaflet device attachment (slda).It was reported through a research article identifying mitraclip that may be related to the following: patient deaths, recurrent mitral regurgitation, leaflet perforation, cardiogenic shock, stroke, myocardial infarction, heart failure, pneumonia, atrial perforation, infection, pseudoaneurysm, fistula, bleeding, renal failure, medical intervention, mitral valve replacement, and hospitalization.Device issues include, single leaflet device attachment (slda), and inability to grasp the leaflets.Details are listed in the attached article, titled ¿acute and midterm outcome after mitraclip therapy in patients with severe mitral regurgitation and left ventricular dysfunction.¿ please see article for additional information.
 
Manufacturer Narrative
The devices were not returned for analysis.A review of the lot histories could not be performed as the lot numbers and part numbers are unknown.A query of the echo analytic reporting system (ears) complaint-handling database to determine similar incidents could not be performed as the lot numbers and the part numbers are unknown.Based on the limited available information and no devices to analyze a cause for the reported single leaflet device attachment (slda) and positioning failure (leaflet grasping ¿ clip not implanted) cannot be determined.There is no indication of a product issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM CLIP DELIVERY SYSTEM
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key11402380
MDR Text Key239512036
Report Number2024168-2021-01651
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial,Followup
Report Date 05/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK CDS
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/08/2021
Initial Date FDA Received03/02/2021
Supplement Dates Manufacturer Received05/12/2021
Supplement Dates FDA Received05/21/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age73 YR
-
-